ResMed holds recent Real Value of $97.2157 per share. The prevailing price of the company is $115.33. At this time the company appears to be over valued. Macroaxis determines value of ResMed from analyzing the company fundamentals such as Shares Outstanding of 142.5M, Operating Margin of
29.63% and Return On Equity of 16.97% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
ResMed Market CapResMed is rated below average in market capitalization category among related companies. Market capitalization of Medical Instruments & Supplies industry is at this time estimated at about 203.51 Billion. ResMed holds roughly 16.43 Billion in market capitalization claiming about 8% of all equities under Medical Instruments & Supplies industry.
|Horizon||30 Days Login to change|
ResMed is rated below average in five year return category among related companies. It is rated below average in price to book category among related companies fabricating about 4.81 of Price to Book per Five Year Return.
|Five Year Return ( % )|
|Price to Book ( times )|
December 14, 2018
ResMed is not too risky asset. Calculation of real value of ResMed is based on 2 months time horizon. Increasing ResMed time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
|Earnings Quarterly Growth||22.80%|
|Enterprise Value To Ebitda||22.41|
|Enterprise Value To Revenue||6.64|